HRTX

NASDAQ 已收盘

Heron Therapeutics

0.25 USD
▼-0.01-4.39%
盘后 0.25 -0.99%
2026-11-20
市值
$48.04M
市盈率
—
EPS
-0.11
股息率
—
52 周区间
0.25 – 1.58
成交量
1.76M
Beta
1.65
目标价
2.00
52W 低 0.2552W 高 1.58
价格走势

公司简介

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emeto...